Section Arrow
DYAI.NASDAQ
- Dyadic International
(Financial Status)
Quotes are at least 15-min delayed:2026/03/28 03:07 EDT
Regular Hours
Last
 0.6787
-0.0225 (-3.21%)
Day High 
0.7489 
Prev. Close
0.7012 
1-M High
1.02 
Volume 
207.22K 
Bid
0.6103
Ask
0.6769
Day Low
0.66 
Open
0.72 
1-M Low
0.6546 
Market Cap 
25.37M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.82 
20-SMA 0.8 
50-SMA 0.83 
52-W High 1.43 
52-W Low 0.6546 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.22/-0.07
Enterprise Value
30.39M
Balance Sheet
Book Value Per Share
0.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.23M
Operating Revenue Per Share
0.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITRMIterum Therapeutics plc0.0356-0.1404-79.77%-- 
ARTLArtelo Biosciences Inc10.54+7.35+230.41%-- 
ONCOOnconetix Inc1.94-1.28-39.75%0PE
RCKTRocket Pharmaceuticals3.77-0.92-19.62%-- 
ADMAADMA Biologics9.25+0.96+11.58%13.87PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.